Article Details
Retrieved on: 2024-02-09 22:27:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective, multi-center, global, ...
Article found on: www.dicardiology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here